Page context
THCV resin for differentiated cannabinoid products.
This page provides supporting information about Cilo Cybin's company platform, products, services, and stakeholder communications.
THCV from Cilo Cybin's GMP cannabinoid API portfolio: ≥95% THCV specification target, hard deep yellow to purple resin when exposed to oxygen.
This page provides supporting information about Cilo Cybin's company platform, products, services, and stakeholder communications.
A specialist THCV resin option for licensed buyers that need a defined rare cannabinoid input for development work.
THCV, or Delta-9-tetrahydrocannabivarin, is a rare minor cannabinoid selected for differentiated wellness, energy-positioned, and weight-management product concepts where the buyer needs a defined non-commodity cannabinoid input. Cilo Cybin presents THCV as a hard resin with a deep yellow colour that may shift toward purple when exposed to oxygen, with a ≥95% THCV specification target and a ≤0.05% THC target.
The commercial interest in THCV is linked to its distinct three-carbon side chain, which differentiates it from THC . Development teams commonly evaluate THCV for non-intoxicating positioning, focus-oriented products, appetite-related concepts, metabolic-support research pathways, and minor-cannabinoid blends. Claims must be confirmed against the destination market and finished-product dossier.
Use these pages to move between adjacent products without losing the family context.
Send the Cilo Cybin team your target format, desired specification, estimated volume, destination market, and documentation requirements.
Pharmaceutical biotechnology for regulated cannabinoid API's, bulk products, finished formats, and partner supply programs.
For partnership, product, or company enquiries, contact Cilo Cybin for the latest approved information.
Page information
This page provides supporting information about Cilo Cybin's company platform, products, services, and stakeholder communications.
For partnership, product, or company enquiries, contact Cilo Cybin for the latest approved information.